Explained | Why USFDA has put plasma therapy for Covid-19 on hold and what it means for India

Explained | Why USFDA has put plasma therapy for Covid-19 on hold and what it means for India A group of top US health officials, including Anthony Fauci, have said that the emerging data on the treatment was too weak for the approval.

No comments:

Post a Comment